International journal of environmental research and public health

safety science

psychiatry research

clinical medicine (london, england)

Cureus

Nature

emerging microbes & infections

Journal of medical virology

The Journal of hospital infection

cell host & microbe

international journal of antimicrobial agents

american journal of otolaryngology

microbes and infection

journal of travel medicine

chembiochem : a european journal of chemical biology

molecular human reproduction

emergency medicine practice

ssrn

[1] The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future.

[2] Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China.

[3] Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV.

[4] CD-sACE2 Inclusion Compounds: An Effective Treatment for Corona Virus Disease 2019 (COVID-19).

[5] Active Surveillance for Suspected COVID-19 Cases in Inpatients with Information Technology.

[6] Ark of Life and Hope：Role of Cabin Hospital in Facing COVID-19.

[7] Beyond the assistance: additional exposure situations to COVID-19 for healthcare workers.

[8] Infection and Rapid Transmission of SARS-CoV-2 in Ferrets.

[9] Calculated decisions: COVID-19 calculators during extreme resource-limited situations.

[10] Unprecedented disruption of lives and work: Health, distress and life satisfaction of working adults in China one month into the COVID-19 outbreak.

[11] Chloroquine and COVID-19 - a potential game changer?

[12] Virological and Clinical Cure in Covid-19 Patients Treated with Hydroxychloroquine: A Systematic Review and Meta-Analysis.

[13] Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.

[14] Focus on Mental Health During the Coronavirus (COVID-19) Pandemic: Applying Learnings from the Past Outbreaks.

[15] Brief Review on COVID-19: The 2020 Pandemic Caused by SARS-CoV-2.

[16] Potential influence of COVID-19/ACE2 on the female reproductive system.

[17] High proportion of asymptomatic and presymptomatic COVID-19 infections in travelers and returning residents to Brunei.

[18] Potential Factors Influencing Repeated SARS Outbreaks in China.

[19] A pneumonia outbreak associated with a new coronavirus of probable bat origin.

[20] The scientific literature on Coronaviruses, COVID-19 and its associated safety-related research dimensions: A scientometric analysis and scoping review.

[21] Arbidol/IFN-α2b Therapy for Patients With Corona Virus Disease 2019: A Retrospective Multicenter Cohort Study.

[22] Pediatric COVID-19: Systematic review of the literature.

[23] Candidate Targets for Immune Responses to 2019-Novel Coronavirus (nCoV): Sequence Homology- and Bioinformatic-Based Predictions.

[24] Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies

[25] What goes on board aircraft? Passengers include Aedes, Anopheles, 2019-nCoV, dengue, Salmonella, Zika, et al.

[26] Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study.

[27] Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event

[28] The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future.

[29] 2019-nCoV: The Identify-Isolate-Inform (3I) Tool Applied to a Novel Emerging Coronavirus.

[30] CT imaging of two cases of one family cluster 2019 novel coronavirus (2019-nCoV) pneumonia: inconsistency between clinical symptoms amelioration and imaging sign progression.

[31] Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations

[32] Rapid random access detection of the novel SARS-coronavirus-2 (SARS-CoV-2, previously 2019-nCoV) using an open access protocol for the Panther Fusion

[33] Cross-species transmission of the newly identified coronavirus 2019-nCoV

[34] The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade

[35] Homology Models of Coronavirus 2019-nCoV 3CLpro Protease

[36] Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV.

[37] Medical journals and the 2019-nCoV outbreak

[38] Outbreak of novel Corona virus (2019-nCoV); implications for travelers to Pakistan

[39] Human Saliva: Non-Invasive Fluid for Detecting Novel Coronavirus (2019-nCoV)

[40] Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.

[41] Clinical characteristics of survivors and non-survivors, medical and non-medical staff members with 2019-nCoV pneumonia in Wuhan, China: a descriptive study

[42] Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2

[43] [Options for controlling new Corona virus infection - 2019-nCoV].

[44] A hybrid fractional optimal control for a novel Coronavirus (2019-nCov) mathematical model

[45] Covid-19 pandemic and the unprecedented mobilisation of scholarly efforts prompted by a health crisis: Scientometric comparisons across SARS, MERS and 2019-nCoV literature.

[46] Isolation, quarantine, social distancing and community containment: pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak

[47] Baricitinib as potential treatment for 2019-nCoV acute respiratory disease